[1] CAO T.Etiology and prevention of oral cancer[J]. Guide of China Medicine(中国医药指南), 2011, 9(14): 199-200. [2] LAU A, LI KY, YANG WF, et al.Induction chemotherapy for squamous cell carcinomas of the oral cavity:A cumulative meta analysis[J]. Oral Oncol, 2016, 61(10): 104-114. [3] WEI N, SUN H, LIU GT.Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance[J]. Acta Pharmaceutica Sinica(药学学报), 2010, 45(10): 1205-1211 [4] MIMEAULT M, HAUKE R, BATRA SK.Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies[J]. Clinical Pharmacology and Therapeutics, 2008, 83(5): 673-691. [5] JULIANO RL, LING V.A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants[J]. Biochim Biophys Acta, 1976, 455(1): 152-162. [6] ISHIKAWA T, NAKAGAWA H, HAGIYA Y, et al.Key role of human abc transporter abcg2 in photodynamic therapy and photodynamic diagnosis[J]. Adv Pharmacol Sci, 2010 (1): 587306. [7] TSURUO T, IIDA H, TSUKAGOSHI S, et al.Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil[J]. Cancer Res, 1981, 41(5): 1967-1972. [8] LAGE H, DUARTE N, COBURGER C, et al.Antitumor activity of terpenoids. against classical and atypical multidrug resistant cancer cells[J]. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 2010, 17(6): 441-448. [9] NOOTER K, BRUTEL DE LA RG, LOOK MP, et al. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer[J]. Br J Cancer , 1997, 76(4): 486-493. [10] BURGER H, FOEKENS JA, LOOK MP, et al.RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response[J]. Clin Cancer Res, 2003, 9(2): 827-836. [11] WEI N.H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein[D]. Beijing: Peking Union Medical College, 2011. [12] GARATTINI S.Pharmacokinetics in cancer chemotherapy[J]. Eur J Cancer, 2007, 43(2): 271-282. [13] LIU XD.Tetrandrine derivatives W6 and W18 reverse MDR by inhibiting P-glycoprotein and 5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells[D]. Beijing: Peking Union Medical College, 2010. [14] DASSA E, BOUIGE P.The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms[J]. Res Microbiol, 2001, 152(3-4): 211-229. [15] DAWSON RJ, LOCHER KP.Structure of a bacterial multidrug ABC transporter[J]. Nature, 2006, 443(7108): 180-185. |